Table 1

The study participants’ demographic and clinical data at the baseline and end point

Baseline (2003–2004)End point (2012–2013)p Value
Age (years)53.7±13.6
Gender (M/F)157/193
Duration (years)11.8±7.8
BMI (kg/m2)25.5±5.025.5±5.00.802
WC (cm)91.9±13.991.9±13.60.983
UpH6.0±0.86.2±2.60.201
PG (mg/dL)129.0±48.0119.4±19.20.734
HbA1c (%)6.9±1.16.5±0.50.0042
SBP (mm Hg)134.5±18.6128.0±10.9<0.0001
DBP (mm Hg)80.1±10.376.4±7.2<0.0001
Heart rate (bpm)73.0±14.170.4±8.5<0.0001
TC (mg/dL)188.3±34.5192.8±25.70.257
TG (mg/dL)120.6±70.2114.8±52.10.583
HDL-C (mg/dL)55.7±15.857.5±15.30.019
BUN (mg/dL)19.6±9.925.5±16.7<0.0001
eGFR (mL/min/1.73 m2)72.7±19.855.5±16.2<0.0001
ACR (mg/g Cre)24.8 (0.0–4735.6)55.1 (3.8–4999.5)<0.0001
UA (mg/dL)6.2±1.76.5±1.40.046
ALT (U/L)23.6±22.626.9±15.2<0.0001
AST (U/L)25.2±16.025.7±9.6<0.0001
K+ (mEq/L)4.4±0.54.5±0.50.676
Na+ (mEq/L)140.8±2.3139.9±2.60.0142
Cl (mEq/L)103.6±3.2105.4±4.60.0002
TP (g/dL)7.2±0.57.1±0.30.0018
Hb (g/dL)12.8±1.713.1±1.30.0030
Plt (104/μL)22.5±6.618.0±10.70.0003
WCC (103/μL)6.2±1.86.1±1.50.241
PWV (cm/s)1573.5±718.71612.3±423.20.283
ABI1.1±0.11.1±0.20.211
IMT (mm)0.7±0.31.3±1.1<0.0001
8-OHdG (ng/mg Cre)9.7±4.5
  • 8-OHdG, 8-hydroxy-2′-deoxyguanosine; ABI, ankle brachial index; ACR, albumin–creatinine ratio; ALT, alanine aminotransferase; AST, aspartate transaminase; BMI, body mass index; BUN, blood urea nitrogen; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; F, female; Hb, hemoglobin; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; IMT, intima-media thickness; M, male; PG, plasma glucose concentration; Plt, platelet; PWV, pulse wave velocity; SBP, systolic blood pressure; TC, serum total cholesterol; TG, serum triglycerides; TP, total protein; UA, uric acid; UpH, urinary pH; WC, waist circumference; WCC, white cell count.